Multicenter study on the long-term (3-year) efficacy of lanthanum carbonate in dialysis patients

Autor: Ryoichi, Ando, Satomi, Yama, Tsuyoshi, Ohnishi, Shunsuke, Iwamoto, Hitoshi, Kimura, Yoshiko, Chida, Yuji, Ishida, Kouei, Yamada, Yuichiro, Inagaki, Masanobu, Takayama, Ken, Tachibana, Kan, Kikuchi, Atsushi, Inoue, Masakazu, Ohtsuka
Rok vydání: 2014
Předmět:
Zdroj: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 18
ISSN: 1744-9987
Popis: We previously conducted a multicenter study enrolling 101 dialysis patients with hyperphosphatemia in which lanthanum carbonate (LC) was administered for 2 years. In this study, the administration has been continued for an additional year, and we have evaluated the long-term (a total of 3 years) effects of LC. The average serum phosphorus (P) level was 6.05 mg/dL at the start and decreased to 5.84 mg/dL after 3 years, but no significant differences were observed at both points. The average serum corrected calcium (Ca) level significantly reduced after 3 years (P0.001). As results of evaluating the achievement rates with the management target values of serum P, Ca and intact parathyroid hormone (PTH) stated in the Japanese guideline, the achievement rates increased after 3 years. From these results, LC is considered to be a useful P binder that can be used for long-term treatment of hyperphosphatemia, without causing a Ca load.
Databáze: OpenAIRE